Danaher: Number of Employees 2010-2025 | DHR

Interactive chart of Danaher (DHR) annual worldwide employee count from 2010 to 2025.
  • Danaher total number of employees in 2024 was 63,000, a 0% decline from 2023.
  • Danaher total number of employees in 2023 was 63,000, a 22.22% decline from 2022.
  • Danaher total number of employees in 2022 was 81,000, a 1.25% increase from 2021.
  • Danaher total number of employees in 2021 was 80,000, a 15.94% increase from 2020.
Danaher Annual Employee Count
2024 63,000
2023 63,000
2022 81,000
2021 80,000
2020 69,000
2019 60,000
2018 71,000
2017 67,000
2016 62,000
2015 81,000
2014 71,000
2013 66,000
2012 63,000
2011 59,000
2010 48,200
2009 46,600
Sector Industry Market Cap Revenue
Medical Medical Services $140.565B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.235B 11.77
CVS Health (CVS) United States $79.418B 9.87
Cencora (COR) United States $56.719B 19.73
DiDi Global (DIDIY) China $21.932B 33.29
Natera (NTRA) United States $20.928B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $13.109B 13.88
EUROFINS SCIENT (ERFSF) Luxembourg $11.943B 0.00
CochLear (CHEOY) Australia $11.734B 0.00
Revvity (RVTY) United States $11.115B 19.13
ICON (ICLR) Ireland $10.559B 9.82
Viatris (VTRS) United States $10.281B 3.53
Doximity (DOCS) United States $10.038B 46.76
Avantor (AVTR) United States $9.104B 13.23
Medpace Holdings (MEDP) United States $8.794B 23.36
HealthEquity (HQY) United States $8.442B 41.53
Sonic Healthcare (SKHHY) Australia $8.311B 0.00
Charles River Laboratories (CRL) United States $6.944B 13.61
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.201B 38.89
Bausch + Lomb (BLCO) Canada $4.160B 24.52
Sotera Health (SHC) United States $3.616B 20.55
Alignment Healthcare (ALHC) United States $3.213B 0.00
Surgery Partners (SGRY) United States $3.025B 39.33
Concentras Parent (CON) United States $2.892B 16.71
Organon (OGN) United States $2.340B 2.49
Ardent Health Partners (ARDT) United States $2.167B 9.24
GeneDx Holdings (WGS) United States $2.026B 78.04
Premier (PINC) United States $1.903B 14.44
Progyny (PGNY) United States $1.843B 40.57
PACS (PACS) United States $1.623B 0.00
GoodRx Holdings (GDRX) United States $1.411B 28.21
Teladoc Health (TDOC) United States $1.282B 0.00
Pediatrix Medical (MD) United States $1.277B 9.72
Establishment Labs Holdings (ESTA) $1.065B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.986B 15.39
Nutex Health (NUTX) United States $0.981B 14.82
Agilon Health (AGL) United States $0.969B 0.00
AMN Healthcare Services Inc (AMN) United States $0.858B 8.04
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.679B 4.57
InnovAge Holding (INNV) United States $0.566B 0.00
Enhabit (EHAB) United States $0.539B 44.38
Auna S.A (AUNA) Luxembourg $0.524B 13.88
Sonida Senior Living (SNDA) United States $0.494B 0.00
LifeMD (LFMD) United States $0.481B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.404B 0.00
SBC Medicals (SBC) United States $0.353B 0.00
Oncology Institute (TOI) United States $0.231B 0.00
Performant Healthcare (PHLT) United States $0.211B 0.00
Beauty Health (SKIN) United States $0.205B 0.00
DocGo (DCGO) United States $0.148B 24.17
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.087B 0.00
KindlyMD (KDLY) United States $0.084B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Basel Medical Group (BMGL) Singapore $0.039B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Pheton Holdings (PTHL) China $0.032B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00